$39.95
+0.21 (+0.53%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+45.33%
1Y
+158.41%
YTD
+54.19%
Open$39.86
Previous Close$39.74
Day High$40.33
Day Low$38.95
52W High$41.23
52W Low$14.32
Volume—
Avg Volume964.8K
Market Cap8.25B
P/E Ratio—
EPS$-2.77
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$25.99
Above
SMA 200
$19.59
Above
RSI (14)
49.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
24 analysts
Price Target
+52.5% upside
Current
$39.95
$39.95
Target
$60.94
$60.94
$43.15
$60.94 avg
$94.48
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.40B | 1.44B | 1.30B |
| Net Income | 261.90M | 339.04M | 251.92M |
| Profit Margin | 18.7% | 23.6% | 19.4% |
| EBITDA | 403.28M | 390.65M | 352.93M |
| Free Cash Flow | 259.22M | 284.01M | 237.35M |
| Rev Growth | +1.7% | -7.0% | +15.8% |
| Debt/Equity | 0.75 | 0.69 | 0.65 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |